Proposal of a novel diabetogenic mechanism involving the serpin PAI-1
✍ Scribed by Sarah L. Griffiths; David J. Grainger
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 356 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0265-9247
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Metabolic Syndrome is a cluster of risk factors (including obesity, hypertension and insulin resistance), which is associated with late‐onset diabetes and coronary heart disease. Elevated levels of the protease inhibitor PAI‐1 are well‐known molecular markers of the Metabolic Syndrome. Here, however, we present a hypothesis that PAI‐1 acts as a causative factor in the development of Metabolic Syndrome and its clinical sequelae. We propose that PAI‐1 inhibits the activity of members of the proprotein convertase (PC) class of serine proteases and that this underlies, at a molecular level, many of the other features of the Metabolic Syndrome cluster. BioEssays 28: 629–641, 2006. © 2006 Wiley Periodicals, Inc.
📜 SIMILAR VOLUMES
The human GSTP1 gene is frequently over-expressed in many human cancers and the expression increases with tumor progression and is associated with a more aggressive biology, poor patient survival, and resistance to therapy. The molecular regulation of the human GSTP1 gene during malignancy is, howev
Population analysis of g.2488delG and three novel polymorphisms (g.4497G>A., g.
## Abstract The TGF‐β signaling pathway has potent anti‐mitogenic effects in epithelial cells and loss of negative growth regulation is often associated with increased tumorigenicity. The human pancreatic ductal adenocarcinoma cell line, UK Pan‐1, which expresses __DPC4__, is not highly responsive
## Abstract The sequential rearrangement reaction mechanism of the 2‐allyl‐2,4,5‐hexatrienaldehyde has been studied at the unrestricted Becke three‐parameter hybrid functional combined with Lee–Yang–Parr correlation functional (UB3LYP)/6‐31G\*\*, Complete Active Space Self‐Consistent Field (CAS (8,